Prime Minister Narendra Modi unveiled three landmark innovations — QSIP, India’s own quantum security chip; the 25-qubit QPU, India’s first quantum computing chip; and CAR-T Cell Therapy, the country’s first indigenous cancer cell therapy — during the Emerging Science, Technology and Innovation Conclave (ESTIC 2025).

Among these, NexCAR19, the world’s first humanised CAR-T therapy developed in India by ImmunoACT, stands out as a transformative, life-saving innovation “Made in India, for the world.” The project was supported by the Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC).

The Chimeric Antigen Receptor T-cell (CAR-T) therapy represents a revolutionary advance in cancer treatment. Global clinical trials have shown remarkable succe

See Full Page